With the 2024 election just weeks away, a new crisis is barrelling down on America… one that could cleave the financial world in two the moment the polls close. I predict they could see investment losses of 50% (or more) in the weeks following the presidential election.

Veeral Desai Biography and Net Worth

Insider of agilon health

Veeral Desai has served as our Chief Strategy and Development Officer since September 2020. Veeral joined agilon health in April 2017 as President of Enterprise Operations. Veeral served in several senior executive roles at Vantage Oncology (most recently as President of Operations, Chief Operating Officer
for Vantage Cancer Care Network) from December 2010 to April 2017. Veeral served as a consultant at Bain & Company from September 2002 to July 2005 and September 2007 to December 2010. Veeral received his B.S. from the University of California, Berkeley and holds an MBA from Harvard Business School.

What is Veeral Desai's net worth?: The estimated net worth of Veeral Desai is at least $558,726.03 as of May 9th, 2023. Mr. Desai owns 299,585 shares of agilon health stock worth more than $558,726 as of November 13th. This net worth approximation does not reflect any other assets that Mr. Desai may own. Learn More about Veeral Desai's net worth.
How do I contact Veeral Desai?: The corporate mailing address for Mr. Desai and other agilon health executives is , , . agilon health can also be reached via phone at 562-256-3800 and via email at [email protected]. Learn More on Veeral Desai's contact information.
Has Veeral Desai been buying or selling shares of agilon health?: Veeral Desai has not been actively trading shares of agilon health in the last ninety days. Most recently, Veeral Desai sold 4,500 shares of the business's stock in a transaction on Tuesday, May 9th. The shares were sold at an average price of $26.15, for a transaction totalling $117,675.00. Following the completion of the sale, the insider now directly owns 299,585 shares of the company's stock, valued at $7,834,147.75. Learn More on Veeral Desai's trading history.
Who are agilon health's active insiders?: agilon health's insider roster includes Joan Danieley (Insider), Veeral Desai (Insider), Theodore Halkias (Insider), Benjamin Kornitzer (Insider), Jeffrey Schwaneke (Director), Steven Sell (CEO), Benjamin Shaker (Insider), Michael Smith (Director), Glenn Sobotka (CAO), and John Wulf (Director). Learn More on agilon health's active insiders.
Are insiders buying or selling shares of agilon health?: During the last twelve months, agilon health insiders bought shares 2 times. They purchased a total of 42,300 shares worth more than $317,406.00. The most recent insider tranaction occured on September, 12th when CEO Steven Sell bought 20,000 shares worth more than $67,200.00. Insiders at agilon health own 3.2% of the company. Learn More about insider trades at agilon health.
Information on this page was last updated on 9/12/2024.

Veeral Desai Insider Trading History at agilon health

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/9/2023	Sell	4,500	$26.15	$117,675.00	299,585
4/20/2023	Sell	500	$26.15	$13,075.00	299,585
7/7/2022	Sell	319,071	$25.00	$7,976,775.00	278,211
6/24/2022	Sell	106,357	$22.50	$2,393,032.50	278,211
4/21/2022	Sell	79,568	$20.54	$1,634,326.72	278,211

Veeral Desai Buying and Selling Activity at agilon health

agilon health Company Overview

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.

Today's Range

Now: $1.87

$1.86

$2.20

50 Day Range

MA: $3.22

$1.84

$4.17

2 Week Range

Now: $1.87

$1.80

$13.76

Volume

6,701,832 shs

Average Volume

4,972,736 shs

Market Capitalization

$767.41 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.6

The most serious warning of my career

From Porter & Company | Ad

Click here now to grab your seat now.